Hologic - HOLX Competitors

Koninklijke Philips (NYSE:PHG) and Hologic (NASDAQ:HOLX) are both large-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, profitability, earnings, community ranking, analyst recommendations, valuation and institutional ownership.

Do insiders & institutionals believe in PHG or HOLX?

10.2% of Koninklijke Philips shares are owned by institutional investors. Comparatively, 95.2% of Hologic shares are owned by institutional investors. 1.7% of Hologic shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Which has more volatility and risk, PHG or HOLX?

Koninklijke Philips has a beta of 0.87, indicating that its share price is 13% less volatile than the S&P 500. Comparatively, Hologic has a beta of 1.01, indicating that its share price is 1% more volatile than the S&P 500.

Which has higher valuation and earnings, PHG or HOLX?

Hologic has lower revenue, but higher earnings than Koninklijke Philips. Koninklijke Philips is trading at a lower price-to-earnings ratio than Hologic, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Koninklijke Philips	$18.79 billion	0.77	-$1.69 billion	-$1.60	-10.18
Hologic	$4.86 billion	4.00	$1.30 billion	$3.92	20.11

Does the MarketBeat Community believe in PHG or HOLX?

Hologic received 466 more outperform votes than Koninklijke Philips when rated by MarketBeat users. Likewise, 70.31% of users gave Hologic an outperform vote while only 57.17% of users gave Koninklijke Philips an outperform vote.

Company	Underperform	Outperform
Koninklijke Philips	Outperform Votes 363 57.17%	Underperform Votes 272 42.83%
Hologic	Outperform Votes 829 70.31%	Underperform Votes 350 29.69%

Do analysts rate PHG or HOLX?

Koninklijke Philips presently has a consensus price target of $16.79, suggesting a potential upside of 3.04%. Hologic has a consensus price target of $84.08, suggesting a potential upside of 6.65%. Given Hologic's stronger consensus rating and higher possible upside, analysts clearly believe Hologic is more favorable than Koninklijke Philips.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Koninklijke Philips	5 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.60
Hologic	0 Sell rating(s)	8 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.47

Is PHG or HOLX more profitable?

Hologic has a net margin of 22.17% compared to Koninklijke Philips' net margin of -7.67%. Hologic's return on equity of 25.12% beat Koninklijke Philips' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Koninklijke Philips	-7.67%	6.86%	3.05%
Hologic	22.17%	25.12%	13.33%

Does the media prefer PHG or HOLX?

In the previous week, Koninklijke Philips and Koninklijke Philips both had 7 articles in the media. Koninklijke Philips' average media sentiment score of 1.09 beat Hologic's score of 0.56 indicating that Koninklijke Philips is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Koninklijke Philips	4 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Hologic	5 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Hologic beats Koninklijke Philips on 15 of the 17 factors compared between the two stocks.